MyBlueDotsOncology & CancerLung cancer trial reveals 40% drop in deaths using biomarker testing MyBlueDots4 weeks ago01 mins New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of lung cancer led to a major reduction in deaths. Go to Source Author: Post navigation Previous: Data-driven study reveals falling use of antiseizure drug in pregnancyNext: AI analysis reveals four long COVID patient subgroups and needs
GLP-1 drug shows little benefit for people with Parkinson’s disease, trial finds MyBlueDots6 hours ago 0
Review finds women health sector leaders good for a nation’s wealth, health, innovation, ethics MyBlueDots6 hours ago 0